Congressional Affairs 2022

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

September 2022

Hearings, Briefings, Meetings

  • August 29, 2002 – NIDA Senior Advisor within the Division of Therapeutics and Medical Consequences, Dr. Aidan Hampson, met with Senator Pocan’s staff to discuss Kratom.
  • September 7, 2022 – NIDA Director Dr. Nora Volkow met with Senator Cornyn’s staff to discuss wastewater epidemiology.

May 2022

Hearings, Briefings, Meetings

  • March 23, 2022 – NIDA Director Dr. Nora Volkow testified at a Senate Health, Education, Labor and Pensions committee hearing title, Strengthening Federal Mental Health and Substance Use Disorder Programs: Opportunities, Challenges, and Emerging Issues.
  • April 19, 2022 – NIDA Director Dr. Nora Volkow met with Representative David Trone and Representative Hal Rogers to discuss the opioid crisis.
  • May 2, 2022 – NIDA Director Dr. Nora Volkow met with Senate Appropriations staff to discuss the NIH Helping to End Addiction Long-term (HEAL) Initiative and the opioid crisis.

February 2022

Hearings, Briefings, Meetings

  • September 27, 2021: Dr. Volkow participating in a Congressional briefing organized by Friends of NIDA and the Partnership to End Addiction titled, New Directions in Substance Use Prevention.
  • November 15, 2021: Dr. Volkow joined Senator Shelley Moore Capito in a tour of the Rockefeller Neuroscience Institute at West Virginia University where she delivered a lecture titled, The Opioid Crisis: Addressing the Challenges Posed by Fentanyl.
  • December 2, 2021: Dr. Volkow testified at a hearing of the House Energy and Commerce Committee’s Subcommittee on Health titled, The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances.